[Suppression of puerperal lactation by metergoline]

Area of Science:

• Endocrinology
• Pharmacology

Context:

• Puerperal lactation, the production of milk after childbirth, can be an unwanted condition in certain clinical scenarios.
• Serotonin antagonists, like metergoline, have shown potential in modulating hormonal pathways involved in lactation.

Purpose:

• To evaluate the efficacy and safety of metergoline for the suppression of puerperal lactation.
• To assess the impact of metergoline on plasma prolactin levels in postpartum women.

Summary:

• Metergoline was administered to 33 postpartum women at varying doses and durations to suppress lactation.
• Lactation was successfully suppressed in most participants, with significant reductions in plasma prolactin levels observed.
• While rebound phenomena occurred in some cases, extended treatment resolved these issues without reported side effects.

Impact:

• Metergoline is a highly effective and safe option for puerperal lactation suppression.
• The study suggests optimal treatment durations to minimize recurrence and ensure sustained suppression.